surgical patients under general anesthesia
Conditions
Interventions
Target-controlled Group (A, B):Group A, inhaling 2.2% vol
Group B, inhaling sevoflurane 2.6% vol
FB behind Fet Group:inhaling sevoflurane 2.4%vol
proved group:inhaling sevoflurane (2.2%vol 2.6%%vol)
Sponsors
Cancer Hospital, Fudan University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients who are scheduled to receive thyroid or breast operation, ASA I
Exclusion criteria
Exclusion criteria: No special exclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fet of sevoflurane;Fraction of brain venous blood of sevoflurane;plasma concentration of EPO;the expression of pre-endogenic opioid genes; | — |
Countries
China
Contacts
Public ContactChen Zhiyang
Outcome results
None listed